"A la carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

Hepatology

Volumn 36, Issue 6, 2002, Pages 1361-1366

  Bureau, Christophe ^a,b   Péron, Jean Marie ^a,b   Alric, Laurent ^a   Morales, Joséphine ^a   Sanchez, Jérôme ^a   Barange, Karl ^a   Payen, Jean Louis ^a   Vinel, Jean Pierre ^a,b  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ISOSORBIDE 5 NITRATE; PROPRANOLOL;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMODYNAMICS; HEMOSTASIS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER VEIN; MALE; MORTALITY; MULTIVARIATE ANALYSIS; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; PORTAL HYPERTENSION; PRESSURE GRADIENT; PRIORITY JOURNAL; VEIN LIGATION; VENOUS PRESSURE; VERTIGO;

EID: 0036896603     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.36945     Document Type: Article

References (26)

1. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. β-Adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991;324:1532-1538.
2. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. β-Adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. Hepatology 1997;25:63-70.
3. Viallet A, Marleau D, Huet M, Martin F, Farley A, Villeneuve JP, Lavoie P. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975;69:1297-1300.
4. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-1407.
5. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Rodes J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056-1059.
6. Villanueva C, Balanzo J, Novella MT, Soriano G, Sainz S, Torras X, Cusso X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996;334:1624-1629.
7. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930-934.
8. Garcia-Pagan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodes J. Enhancement of portal pressure reduction by the association of isosorbide-5mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990;11:230-238.
9. Garcia-Pagan JC, Feu F, Bosch J, Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 1991;114:869-873.
10. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, et al. Portal hypertension and variceal bleeding: An AASLD single topic symposium. Hepatology 1998;28:868-880.
11. Vinel JP, Schuller P, Hervieu C, Cales P, Cassigneul J, Pascal JP. Outcome of patients after obliteration of esophageal varices by endoscopic sclerosis. Results of a prospective study. Gastroenterol Clin Biol 1986;10:584-588.
12. Vinel JP, Monnin JL, Combis JM, Cales P, Desmorat H, Pascal JP. Hemodynamic evaluation of molsidomine: A vasodilator with antianginal properties in patients with alcoholic cirrhosis. Hepatology 1990;11:239-242.
13. Cales P, Grasset D, Ravaud A, Meskens C, Blanc M, Vinel JP, Cotonat J, et al. Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension. Br J Clin Pharmacol 1989;27:763-770.
14. Castaneda B, Morales J, Lionetti R, Moitinho E, Andreu V, Perez-Del-Pulgar S, Pizcueta P, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology 2001;33:821-825.
15. Valla D, Jiron MI, Poynard T, Braillon A, Lebrec D. Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol. J Hepatol 1987;5:144-148.
16. McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK. Clinical vs. haemodynamic response to drugs in portal hypertension. J Hepatol 1998;28:1015-1019.
17. Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Bermann MM, Patrick MJ, Morse SS, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986;6:101-106.
18. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;334:647-655.
19. Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997;113:1632-1639.
20. Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, et al. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: Long-term hemodynamic and renal effects. Hepatology 1993;18:477-484.
21. Groszmann RJ. β-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: The good, the bad, the ugly. Gastroenterology 1997;113:1794-1797.
22. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, Morel I, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study. Gastroenterology 1996;111:701-709.
23. Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: An experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982;83:338-340.
24. Haag K, Rossle M, Ochs A, Huber M, Siegerstetter V, Olschewski M, Berger E, et al. Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. AJR Am J Roentgenol 1999;172:631-635.
25. Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, Navasa M, et al. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 1986;6:667-672.
26. Escorsell A, Bordas JM, Castaneda B, Llach J, Garcia-Pagan JC, Rodes J, Bosch J. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000;31:1061-1067.